Amylin (AMLN) Shares Surge 50+% Amid Rumor Co. Rejected $3.5B Bid from Bristol (BMY)
Tweet
Share
E-mailGet Alerts AMLN Hot Sheet
Join SI Premium – FREE
Amylin (Nasdaq: AMLN) shares surged more than 50 percent following a Bloomberg headline suggesting the company rejected a $3.5 billion bid from Bristol-Myers (NYSE: BMY). The company's market cap as of yesterday's closing price was $2.27 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shares in this major AI chipmakers are "inexpensive": Barclays
- Mizuho TMT specialist flags 2 tech stocks to buy
- Estée Lauder expected to post 1.8% Q4 sales growth as skincare rebounds
Create E-mail Alert Related Categories
Hot List, Momentum Movers, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
